Curtis K. Johnston, Pharm.D.

Senior Scientist II

Curtis joined Metrum in 2014 after receiving his Pharm.D. from the University at Buffalo and completing a clinical PK/PD Fellowship through UNC Chapel Hill/Quintiles. His clinical experience includes infectious disease (bacterial), oncology, and chronic liver disease (HCV and NASH). Curtis’s research interests include Bayesian methodology and the application of M&S to help inform drug development decisions.

Recent publications by this scientist

Population pharmacokinetics of morphine in patients with nonalcoholic steatohepatitis (NASH) and healthy adults

April 7, 2017

Pierre V, Johnston C, Ferslew B, Brouwer K, Gonzalez D.  CPT: Pharmacometrics & Systems Pharmacology. 2017;6(5):331-339. doi:10.1002/psp4.12185.

Download PDF

Population pharmacokinetic modeling of intravenous asparaginase erwinia chrysanthemi: Impact of varied infusion rates on exposure

December 7, 2016

Zomorodi K, Dumas T, Berry S, Johnston C, and Eller M. 

Download PDF

Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis

April 6, 2015

Ferslew B, Johnston C, Tsakalozou E, Bridges A, Paine M, Jia W, Stewart P, Barritt A and Brouwer K. Clinical Pharmacology and Therapeutics, 97: 419–427. doi:10.1002/cpt.66

Download PDF